The European Union’s drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of the COVID-19 pill from Merck & Co Inc https://www.reuters.com/companies/MRK.N” target=”_blank” rel=”noopener”>(MRK.N)Read More
About The Author
